HIV, cholesterol-lowering and cancer medicines dominate price disclosure reductions for April 2020 with almost thirty medicines across over 60 dosages and manners of administration taking an average cut of just over 20 per cent. …
Latest Video
New Stories
-
COVID-19: Pfizer the latest to announce positive vaccine data
July 3, 2020 - - Latest News -
COVID-19: Positive news on Affinity Biosciences antibodies
July 3, 2020 - - Latest News -
Funding for new Sanofi haemophilia treatments
July 3, 2020 - - Latest News -
COVID-19: New data reveals slump in new cancer treatment
July 2, 2020 - - Latest News -
COVID-19: FDA will not compromise standards on vaccine approval
July 2, 2020 - - Latest News -
Roche unveils new organisational 'system'
July 2, 2020 - - Latest News -
Mylan shareholders approve merger with Pfizer's Upjohn
July 2, 2020 - - Latest News